1. Home
  2. SIDU vs MOLN Comparison

SIDU vs MOLN Comparison

Compare SIDU & MOLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sidus Space Inc.

SIDU

Sidus Space Inc.

HOLD

Current Price

$2.69

Market Cap

159.0M

ML Signal

HOLD

Logo Molecular Partners AG

MOLN

Molecular Partners AG

N/A

Current Price

$4.30

Market Cap

158.9M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
SIDU
MOLN
Founded
2012
2004
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Telecommunications Equipment
Sector
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
159.0M
158.9M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
SIDU
MOLN
Price
$2.69
$4.30
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$8.38
AVG Volume (30 Days)
5.8M
3.6K
Earning Date
05-14-2026
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
84.42
N/A
EPS
N/A
N/A
Revenue
$4,672,646.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$100.00
$318.52
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.63
$3.36
52 Week High
$5.39
$5.36

Technical Indicators

Market Signals
Indicator
SIDU
MOLN
Relative Strength Index (RSI) 60.12 40.25
Support Level $0.89 $4.04
Resistance Level $4.40 $4.63
Average True Range (ATR) 0.28 0.27
MACD 0.10 -0.06
Stochastic Oscillator 65.76 16.45

Price Performance

Historical Comparison
SIDU
MOLN

About SIDU Sidus Space Inc.

Sidus Space Inc is a Space and Defense as-a-Service company focused on providing complex space hardware, satellite/spacecraft design, manufacture, launch, and data solutions for both government and commercial in-space missions for all destinations through the solar system. This includes a Space-based infrastructure of multi-mission satellites with hyperspectral, multi-spectral, and other sensors to provide monitoring services and solutions to multiple sectors and industries. The company supports Commercial Space, Aerospace, Defense, Underwater Marine, and other commercial and government customers.

About MOLN Molecular Partners AG

Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.

Share on Social Networks: